These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29508649)

  • 21. Preeclampsia: an update.
    Lambert G; Brichant JF; Hartstein G; Bonhomme V; Dewandre PY
    Acta Anaesthesiol Belg; 2014; 65(4):137-49. PubMed ID: 25622379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spiral artery of placenta: development and pathology-immunohistochemical, microscopical, and electron-microscopic study.
    Hirano H; Imai Y; Ito H
    Kobe J Med Sci; 2002 Apr; 48(1-2):13-23. PubMed ID: 11912350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Insights into the Role of Matrix Metalloproteinases in Preeclampsia.
    Espino Y Sosa S; Flores-Pliego A; Espejel-Nuñez A; Medina-Bastidas D; Vadillo-Ortega F; Zaga-Clavellina V; Estrada-Gutierrez G
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Trophoblast invasion in pre-eclampsia].
    Reister F; Heyl W; Kaufmann P; Rath W
    Zentralbl Gynakol; 1999; 121(12):587-90. PubMed ID: 10666868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preeclampsia: current understanding of the molecular basis of vascular dysfunction.
    Sankaralingam S; Arenas IA; Lalu MM; Davidge ST
    Expert Rev Mol Med; 2006 Jan; 8(3):1-20. PubMed ID: 16438753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
    Tournaye H; Sukhikh GT; Kahler E; Griesinger G
    Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypertension and pregnancy. Diagnosis, physiopathology and treatment].
    Fournier A; Fievet P; el Esper I; el Esper N; Vaillant P; Gondry J
    Schweiz Med Wochenschr; 1995 Nov; 125(47):2273-98. PubMed ID: 8539576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dydrogesterone use in early pregnancy.
    Mirza FG; Patki A; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dydrogesterone in threatened miscarriage: a Malaysian experience.
    Pandian RU
    Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathophysiology and clinical manifestations in pre-eclampsia].
    Haram K; Bjørge L; Guttu K
    Tidsskr Nor Laegeforen; 2000 May; 120(12):1426-31. PubMed ID: 10851940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors, pregnancy complications, and prevention of hypertensive disorders in women with pregravid diabetes mellitus.
    Sibai BM
    J Matern Fetal Med; 2000; 9(1):62-5. PubMed ID: 10757438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placental pathology in pregnancy complications.
    Huppertz B
    Thromb Res; 2011 Feb; 127 Suppl 3():S96-9. PubMed ID: 21262454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examination of distinct fetal and maternal molecular pathways suggests a mechanism for the development of preeclampsia.
    Goldman-Wohl DS; Yagel S
    J Reprod Immunol; 2007 Dec; 76(1-2):54-60. PubMed ID: 17482678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial.
    Ebrashy A; Ibrahim M; Marzook A; Yousef D
    Croat Med J; 2005 Oct; 46(5):826-31. PubMed ID: 16158479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dydrogesterone support in threatened miscarriage.
    El-Zibdeh MY; Yousef LT
    Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary placental growth factor and risk of preeclampsia.
    Levine RJ; Thadhani R; Qian C; Lam C; Lim KH; Yu KF; Blink AL; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    JAMA; 2005 Jan; 293(1):77-85. PubMed ID: 15632339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single administration of ultra-low-dose lipopolysaccharide in rat early pregnancy induces TLR4 activation in the placenta contributing to preeclampsia.
    Xue P; Zheng M; Gong P; Lin C; Zhou J; Li Y; Shen L; Diao Z; Yan G; Sun H; Hu Y
    PLoS One; 2015; 10(4):e0124001. PubMed ID: 25853857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy.
    Verlohren S; Geusens N; Morton J; Verhaegen I; Hering L; Herse F; Dudenhausen JW; Muller DN; Luft FC; Cartwright JE; Davidge ST; Pijnenborg R; Dechend R
    Hypertension; 2010 Aug; 56(2):304-10. PubMed ID: 20606107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dydrogesterone in threatened abortion: pregnancy outcome.
    Omar MH; Mashita MK; Lim PS; Jamil MA
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):421-5. PubMed ID: 16293412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review: Preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses.
    Staff AC; Dechend R; Redman CW
    Placenta; 2013 Mar; 34 Suppl():S73-8. PubMed ID: 23246096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.